Emerging technologies in genetics, pharmacogenetics, genomics, advanced therapies as weel as ICT applications represent today the most advanced tools incorporated in the drug discovery and research & development process used for producing the largest part of the innovative medicines.
Thus, regulation and guidance have to be continuously adapted and updated to guarantee clinical benefits, economic and health outcome improvements, as well as the respect of fundamental and patient rights.
Legal, ethical and regulatory issues of innovation in medicine and helthcare will be analysed within this workshop.